BMJ Evidence-Based Medicine最新文献

筛选
英文 中文
Stop searching and you will find it: Search-Resistant Concepts in systematic review searches. 停止搜索,你就能找到它:系统综述搜索中的搜索抗性概念。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2025-03-21 DOI: 10.1136/bmjebm-2023-112798
Farhad Shokraneh
{"title":"Stop searching and you will find it: Search-Resistant Concepts in systematic review searches.","authors":"Farhad Shokraneh","doi":"10.1136/bmjebm-2023-112798","DOIUrl":"10.1136/bmjebm-2023-112798","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"134-137"},"PeriodicalIF":9.0,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141896731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hurdles of trying to avoid low-value care: two cheers for Choosing Wisely. 试图避免低价值医疗的障碍:为《明智的选择》欢呼两声。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2025-03-21 DOI: 10.1136/bmjebm-2024-113283
Dena S Davis
{"title":"Hurdles of trying to avoid low-value care: two cheers for Choosing Wisely.","authors":"Dena S Davis","doi":"10.1136/bmjebm-2024-113283","DOIUrl":"10.1136/bmjebm-2024-113283","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"138-139"},"PeriodicalIF":9.0,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142963746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapid review method series: interim guidance for the reporting of rapid reviews. 快速审查方法系列:快速审查报告临时指南。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2025-03-21 DOI: 10.1136/bmjebm-2024-112899
Adrienne Stevens, Mona Hersi, Chantelle Garritty, Lisa Hartling, Beverley J Shea, Lesley A Stewart, Vivian Andrea Welch, Andrea C Tricco
{"title":"Rapid review method series: interim guidance for the reporting of rapid reviews.","authors":"Adrienne Stevens, Mona Hersi, Chantelle Garritty, Lisa Hartling, Beverley J Shea, Lesley A Stewart, Vivian Andrea Welch, Andrea C Tricco","doi":"10.1136/bmjebm-2024-112899","DOIUrl":"10.1136/bmjebm-2024-112899","url":null,"abstract":"<p><p>Rapid reviews (RRs) are produced using abbreviated methods compared with standard systematic reviews (SR) to expedite the process for decision-making. This paper provides interim guidance to support the complete reporting of RRs. Recommendations emerged from a survey informed by empirical studies of RR reporting, in addition to collective experience. RR producers should use existing, robustly developed reporting guidelines as the foundation for writing RRs: notably Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 (PRISMA 2020; reporting for SRs), but also preferred reporting items for overviews of reviews (PRIOR) items (reporting for overviews of SRs) where SRs are included in the RR. In addition, a minimum set of six items were identified for RRs: three items pertaining to methods and three addressing publication ethics. Authors should be reporting what a priori-defined iterative methods were used during conduct, what distinguishes their RR from an SR, and knowledge user (eg, policymaker) involvement in the process. Explicitly reporting deviations from standard SR methods, including omitted steps, is important. The inclusion of publication ethics items reflects the predominance of non-journal published RRs: reporting an authorship byline and corresponding author, acknowledging other contributors, and reporting the use of expert peer review. As various formats may be used when packaging and presenting information to decision-makers, it is practical to think of complete reporting as across a set of explicitly linked documents made available in an open-access journal or repository that is barrier-free. We encourage feedback from the RR community of the use of these items as we look to develop a consolidated list in the development of PRISMA-RR.</p>","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"118-123"},"PeriodicalIF":9.0,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141747432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Approach of patient involvement in systematic review development. 患者参与系统评价开发的方法。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2025-03-21 DOI: 10.1136/bmjebm-2024-113368
Omar Ammous, Maximilian Zimmermann, Maximilian Wollsching-Strobel, Tim Mathes
{"title":"Approach of patient involvement in systematic review development.","authors":"Omar Ammous, Maximilian Zimmermann, Maximilian Wollsching-Strobel, Tim Mathes","doi":"10.1136/bmjebm-2024-113368","DOIUrl":"10.1136/bmjebm-2024-113368","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"140-142"},"PeriodicalIF":9.0,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142812141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reducing the environmental impact of healthcare to improve health, sustainability and equity. 减少医疗保健对环境的影响,以改善健康、可持续性和公平性。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2025-03-21 DOI: 10.1136/bmjebm-2024-113124
Maria-Inti Metzendorf, Eva Madrid, Erik van Raaij
{"title":"Reducing the environmental impact of healthcare to improve health, sustainability and equity.","authors":"Maria-Inti Metzendorf, Eva Madrid, Erik van Raaij","doi":"10.1136/bmjebm-2024-113124","DOIUrl":"10.1136/bmjebm-2024-113124","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"75-76"},"PeriodicalIF":9.0,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143027721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can the HEARTS initiative reduce the burden of cardiovascular disease? HEARTS 计划能否减轻心血管疾病的负担?
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2025-03-21 DOI: 10.1136/bmjebm-2023-112590
Martin O'Flaherty, Nikkil Sudharsanan, Chris Kypridemos
{"title":"Can the HEARTS initiative reduce the burden of cardiovascular disease?","authors":"Martin O'Flaherty, Nikkil Sudharsanan, Chris Kypridemos","doi":"10.1136/bmjebm-2023-112590","DOIUrl":"10.1136/bmjebm-2023-112590","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"77-79"},"PeriodicalIF":9.0,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140189487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ten recommendations to foster healthcare resource stewardship in knowledge translation. 在知识转化过程中促进医疗资源管理的十项建议。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2025-03-21 DOI: 10.1136/bmjebm-2024-112914
Rene Wittmer, Guylene Theriault, Frantz-Daniel Lafortune, Samuel Boudreault, Marc-Antoine Turgeon, Pascale Breault, Genevieve Bois, Lisa Hannane, Amanda Try
{"title":"Ten recommendations to foster healthcare resource stewardship in knowledge translation.","authors":"Rene Wittmer, Guylene Theriault, Frantz-Daniel Lafortune, Samuel Boudreault, Marc-Antoine Turgeon, Pascale Breault, Genevieve Bois, Lisa Hannane, Amanda Try","doi":"10.1136/bmjebm-2024-112914","DOIUrl":"10.1136/bmjebm-2024-112914","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"127-129"},"PeriodicalIF":9.0,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141305389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overdiagnosis and Barrett's oesophagus: a call for clarity. 过度诊断和巴雷特食道:呼吁澄清。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2025-03-21 DOI: 10.1136/bmjebm-2024-113260
Elspeth Davies
{"title":"Overdiagnosis and Barrett's oesophagus: a call for clarity.","authors":"Elspeth Davies","doi":"10.1136/bmjebm-2024-113260","DOIUrl":"10.1136/bmjebm-2024-113260","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"143-144"},"PeriodicalIF":9.0,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142791122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The path of Chile towards the institutionalisation of evidence-based health policy. 智利实现循证卫生政策制度化的道路。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2025-03-20 DOI: 10.1136/bmjebm-2024-113006
Paula García-Celedón, Deborah Navarro-Rosenblatt, Carolina Ibarra-Castillo, Lucy Kuhn-Barrientos, Cristián Mansilla, Dino Sepúlveda
{"title":"The path of Chile towards the institutionalisation of evidence-based health policy.","authors":"Paula García-Celedón, Deborah Navarro-Rosenblatt, Carolina Ibarra-Castillo, Lucy Kuhn-Barrientos, Cristián Mansilla, Dino Sepúlveda","doi":"10.1136/bmjebm-2024-113006","DOIUrl":"https://doi.org/10.1136/bmjebm-2024-113006","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":""},"PeriodicalIF":9.0,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143668660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is health technology assessment value for money? Estimating the return on investment of health technology assessment in India (HTAIn). 卫生技术评估物有所值吗?估计印度卫生技术评估的投资回报(HTAIn)。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2025-03-20 DOI: 10.1136/bmjebm-2023-112487
Pankaj Bahuguna, Peter Alan Baker, Andrew Briggs, Sophie Gulliver, Hannah Hesselgreaves, Abha Mehndiratta, Francis Ruiz, Kirti Tyagi, Olivia Wu, Javier Guzman, Eleanor Grieve
{"title":"Is health technology assessment value for money? Estimating the return on investment of health technology assessment in India (HTAIn).","authors":"Pankaj Bahuguna, Peter Alan Baker, Andrew Briggs, Sophie Gulliver, Hannah Hesselgreaves, Abha Mehndiratta, Francis Ruiz, Kirti Tyagi, Olivia Wu, Javier Guzman, Eleanor Grieve","doi":"10.1136/bmjebm-2023-112487","DOIUrl":"https://doi.org/10.1136/bmjebm-2023-112487","url":null,"abstract":"<p><p>An increasing investment in health technology assessment (HTA) in low-income and middle-income countries has generated greater interest from policy-makers about the value and return on investment (ROI) of HTA. Few studies have, however, quantified the benefits of HTA in terms of its value to the health system. This evaluation aims to quantify the impact and ROI achieved by the HTA agency in India (HTAIn).A framework developed by the University of Glasgow was used to review three 'hta's commissioned by HTAIn between 2018 and 2020, taking into account the opportunity cost of investing in these processes. Costs included fixed costs for HTAIn and costs for undertaking each 'hta'. Attributable benefits are calculated by subtracting the counterfactual (benefits that might have been realised without an HTA) from realised benefits.HTAIn sits under the Department of Health Research, Ministry of Health and Family Welfare, Government of India. It was set up to facilitate the process of transparent and evidence-informed decision-making in healthcare in India.HTA helps decision-makers to understand the consequences of alternative courses of action and to select the options that produce the best outcomes at the lowest cost. Institutionalisation of HTA is seen as pivotal to supporting universal health coverage as a means of supporting a better allocation of finite resources, cost containment and the maximisation of health.Net health benefits are our measure of value. The ROI of HTAIn is calculated by aggregating attributable benefits and offsetting them against the costs of investment.Our findings show that investing in HTAIn yields a return of 9:1, with potential to increase to 71:1 with full implementation of HTA recommendations. Variability of ROI ranged from 5:1 to 40:1 between the different interventions and diseases.While HTAIn requires financial investment, it is an efficient use of resources. The potential for greater impact and the variability of the ROI between interventions underline the importance of planning for implementation and good topic selection in HTA.</p>","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":""},"PeriodicalIF":9.0,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143668657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信